Objectives
After participating in this educational activity, attendees should be able to:
1. Describe the phenotypes of elite and viremic HIV controllers.
2. Report on sexual health clinic data during the pandemic
3. Discuss novel ways to expand outreach and testing.
4. Discuss novel ways to broaden PrEP accessibility.
5. Review new medications for PrEP and new multipurpose technologies for prevention.
Faculty
Amanda Westlake, MD
Physician
Baystate Medical Center
Jonna Gaberman, MD
Physician
Baystate Medical Center
Faculty Disclosure
The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Faculty or planner conflicts of interest are resolved before the educational activity.
Daniel Skiest, MD (planner) receives grant support from Hoffman-LaRoche for clinical research study, not HIV related.
None of the other members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 BCIPE Instructional Hours